These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24794830)

  • 1. A recurrent 'hot spot' glycine substitution mutation, G2043R in COL7A1, induces dominant dystrophic epidermolysis bullosa associated with intracytoplasmic accumulation of pro-collagen VII.
    Nishie W; Natsuga K; Nakamura H; Ito T; Toyonaga E; Sato H; Shimizu H
    J Dermatol Sci; 2014 Jul; 75(1):69-71. PubMed ID: 24794830
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa.
    Dang N; Murrell DF
    Exp Dermatol; 2008 Jul; 17(7):553-68. PubMed ID: 18558993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In this issue: glycine substitution mutations in the COL7A1 gene: implications for inheritance of dystrophic epidermolysis bullosa - dominant vs. recessive.
    Uitto J
    Acta Derm Venereol; 2011 May; 91(3):259-61. PubMed ID: 21547333
    [No Abstract]   [Full Text] [Related]  

  • 4. Identical glycine substitution mutations in type VII collagen may underlie both dominant and recessive forms of dystrophic epidermolysis bullosa.
    Almaani N; Liu L; Dopping-Hepenstal PJ; Lai-Cheong JE; Wong A; Nanda A; Moss C; Martinéz AE; Mellerio JE; McGrath JA
    Acta Derm Venereol; 2011 May; 91(3):262-6. PubMed ID: 21448560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of collagen VII sequence variants found in Australasian patients with dystrophic epidermolysis bullosa reveals nine novel COL7A1 variants.
    Dang N; Klingberg S; Marr P; Murrell DF
    J Dermatol Sci; 2007 Jun; 46(3):169-78. PubMed ID: 17425959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycine substitution mutations by different amino acids at the same codon in COL7A1 cause different modes of dystrophic epidermolysis bullosa inheritance.
    Sawamura D; Mochitomi Y; Kanzaki T; Nakamura H; Shimizu H
    Br J Dermatol; 2006 Oct; 155(4):834-7. PubMed ID: 16965438
    [No Abstract]   [Full Text] [Related]  

  • 7. Compound heterozygosity for silent and dominant glycine substitution mutations in COL7A1 leads to a marked transient intracytoplasmic retention of procollagen VII and a moderately severe dystrophic epidermolysis bullosa phenotype.
    Shimizu H; Hammami-Hauasli N; Hatta N; Nishikawa T; Bruckner-Tuderman L
    J Invest Dermatol; 1999 Sep; 113(3):419-21. PubMed ID: 10469344
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel and recurrent COL7A1 mutations in Chilean patients with dystrophic epidermolysis bullosa.
    Rodríguez FA; Gana MJ; Yubero MJ; Zillmann G; Krämer SM; Catalán J; Rubio-Astudillo J; González S; Liu L; Ozoemena L; Mellerio JE; McGrath JA; Palisson F; Conget P
    J Dermatol Sci; 2012 Feb; 65(2):149-52. PubMed ID: 22209565
    [No Abstract]   [Full Text] [Related]  

  • 9. A novel glycine mutation in the COL7A1 gene leading to dominant dystrophic epidermolysis bullosa with intra-familial phenotypical heterogeneity.
    Riedl E; Klausegger A; Bauer JW; Foedinger D; Kittler H
    Pediatr Dermatol; 2009; 26(1):115-7. PubMed ID: 19250433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild recessive dystrophic epidermolysis bullosa associated with two compound heterozygous COL7A1 mutations.
    von Bartenwerffer W; Has C; Arin MJ; Tantcheva-Poór I; Kreuter A; Kremer K; Arshah T; Hoffmann M; Eming SA; Kohlhase J; Krieg T; Bruckner-Tuderman L; Hartmann K
    Eur J Dermatol; 2011; 21(2):170-2. PubMed ID: 21382783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inversa type of recessive dystrophic epidermolysis bullosa is caused by specific arginine and glycine substitutions in type VII collagen.
    van den Akker PC; Mellerio JE; Martinez AE; Liu L; Meijer R; Dopping-Hepenstal PJ; van Essen AJ; Scheffer H; Hofstra RM; McGrath JA; Jonkman MF
    J Med Genet; 2011 Mar; 48(3):160-7. PubMed ID: 21113014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of patients with recessive dystrophic epidermolysis bullosa in the Netherlands: expansion of the mutation database and unusual phenotype-genotype correlations.
    van den Akker PC; van Essen AJ; Kraak MM; Meijer R; Nijenhuis M; Meijer G; Hofstra RM; Pas HH; Scheffer H; Jonkman MF
    J Dermatol Sci; 2009 Oct; 56(1):9-18. PubMed ID: 19665875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominant dystrophic epidermolysis bullosa (Pasini) caused by a novel glycine substitution mutation in the type VII collagen gene (COL7A1).
    Jonkman MF; Moreno G; Rouan F; Oranje AP; Pulkkinen L; Uitto J
    J Invest Dermatol; 1999 May; 112(5):815-7. PubMed ID: 10233777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rat model for dominant dystrophic epidermolysis bullosa: glycine substitution reduces collagen VII stability and shows gene-dosage effect.
    Nyström A; Buttgereit J; Bader M; Shmidt T; Ozcelik C; Hausser I; Bruckner-Tuderman L; Kern JS
    PLoS One; 2013; 8(5):e64243. PubMed ID: 23717576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The G2028R glycine substitution mutation in COL7A1 leads to marked inter-familiar clinical heterogeneity in dominant dystrophic epidermolysis bullosa.
    Nakamura H; Sawamura D; Goto M; Sato-Matsumura KC; LaDuca J; Lee JY; Masunaga T; Shimizu H
    J Dermatol Sci; 2004 May; 34(3):195-200. PubMed ID: 15113589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monozygotic twins discordant for recessive dystrophic epidermolysis bullosa phenotype highlight the role of TGF-β signalling in modifying disease severity.
    Odorisio T; Di Salvio M; Orecchia A; Di Zenzo G; Piccinni E; Cianfarani F; Travaglione A; Uva P; Bellei B; Conti A; Zambruno G; Castiglia D
    Hum Mol Genet; 2014 Aug; 23(15):3907-22. PubMed ID: 24599399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel COL7A1 splice site mutation in severe generalized recessive dystrophic epidermolysis bullosa.
    Jeon IK; Kim SE; Kim SC
    J Dermatol; 2014 Apr; 41(4):350-1. PubMed ID: 24533879
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel p.Gly1700Asp mutation in COL7A1 responsible for dominant dystrophic epidermolysis bullosa: more severe phenotype in female members of a Chinese family.
    Deng W; Chen S; Lu C; Zhou X; Hu B; Chen M; Lai W; Wang Y
    J Dermatol Sci; 2008 Feb; 49(2):166-9. PubMed ID: 17900868
    [No Abstract]   [Full Text] [Related]  

  • 19. Modulation of disease severity of dystrophic epidermolysis bullosa by a splice site mutation in combination with a missense mutation in the COL7A1 gene.
    Winberg JO; Hammami-Hauasli N; Nilssen O; Anton-Lamprecht I; Naylor SL; Kerbacher K; Zimmermann M; Krajci P; Gedde-Dahl T; Bruckner-Tuderman L
    Hum Mol Genet; 1997 Jul; 6(7):1125-35. PubMed ID: 9215684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of recessive dystrophic epidermolysis bullosa caused by compound heterozygous mutations in the COL7A1 gene.
    Suzuki S; Shimomura Y; Yamamoto Y; Kariya N; Shibuya M; Ito M; Fujiwara H
    Br J Dermatol; 2006 Oct; 155(4):838-40. PubMed ID: 16965439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.